Abstract:Background: Methylation is a common epigenetic modification which may play a crucial role in cancer development. To investigate the association between methylation of COX-2 in blood leukocyte DNA and risk of gastric cancer (GC), a nested case-control study was conducted in Linqu County, Shandong Province, a high risk area of GC in China.Methods: Association between blood leukocyte DNA methylation of COX-2 and risk of GC was investigated in 133 GCs and 285 superficial gastritis (SG)/ chronic atrophic gastritis (CAG). The temporal trend of COX-2 methylation level during GC development was further explored in 74 pre-GC and 95 post-GC samples (including 31 cases with both pre- and post-GC samples). In addition, the association of DNA methylation and risk of progression to GC was evaluated in 74 pre-GC samples and their relevant intestinal metaplasia (IM)/dysplasia (DYS) controls. Methylation level was determined by quantitative methylation-specific PCR (QMSP). Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated by unconditional logistic regression analysis.Results: The medians of COX-2 methylation levels were 2.3 % and 2.2 % in GC cases and controls, respectively. No significant association was found between COX-2 methylation and risk of GC (OR, 1.15; 95 % CI: 0.70-1.88). However, the temporal trend analysis showed that COX-2 methylation levels were elevated at 1-4 years ahead of clinical GC diagnosis compared with the year of GC diagnosis (3.0 % vs. 2.2 %, p = 0.01). Further validation in 31 GCs with both pre- and post-GC samples indicated that COX-2 methylation levels were significantly decreased at the year of GC diagnosis compared with pre-GC samples (1.5 % vs. 2.5 %, p = 0.02). No significant association between COX-2 methylation and risk of progression to GC was found in subjects with IM (OR, 0.50; 95 % CI: 0.18-1.42) or DYS (OR, 0.70; 95 % CI: 0.23-2.18). Additionally, we found that elder people had increased risk of COX-2 hypermethylation (OR, 1.55; 95 % CI: 1.02-2.36) and subjects who ever infected with H. pylori had decreased risk of COX-2 hypermethylation (OR, 0.54; 95 % CI: 0.34-0.88).Conclusions: COX-2 methylation exists in blood leukocyte DNA but at a low level. COX-2 methylation levels in blood leukocyte DNA may change during GC development.

Quantification of cyclooxygenase-2 methylation in gastric mucosa by denaturing high performance liquid chromatography assay

[Association Between Promoter Methylation of Cyclooxygenase-2 and Expression, and Precancerous Gastric Lesions in a High-Risk Population].

Mechanism and Clinical Significance of Cyclooxygenase-2 Expression in Gastric Cancer

Methylation Status of Cox-2 in Blood Leukocyte Dna and Risk of Gastric Cancer in A High-Risk Chinese Population

Infrequent COX-2 Expression Due to Promoter Hypermethylation in Gastric Cancers in Dalian, China.

[Quantification of Methylation of SNCG CpG Islands in Human Tissue Samples by the Combined COBRA-DHPLC Assay].

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Alterations of Cyclooxygenase-2 Methylation Levels Before and after Intervention Trial to Prevent Gastric Cancer in a Chinese Population

Simultaneous Detection Of Cpg Methylation And Single Nucleotide Polymorphism By Denaturing High Performance Liquid Chromatography

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

Detection of CPG Methylations in Human Mismatch Repair Gene Hmlh1 Promoter by Denaturing High-Performance Liquid Chromatography (DHPLC)

[Detection of Methylation in Hepatocellular Carcinoma Using SYBR Green Fluorescent Quantitative PCR].

Quantification of Cyclooxygenase-2 Gene Expression in Colorectal Cancer by Real-Time Polymerase Chain Reaction

Establishment of HRM Method for Quantitative Determination for Methylation Level of DLC-1 Promoter in Prostate Cancer and Its Clinical Significance

Prostaglandin E2 induces DNA hypermethylation in gastric cancer in vitro and in vivo

Methylation Status of Individual CpG Sites Within Alu Elements in the Human Genome and Alu Hypomethylation in Gastric Carcinomas

Expression and clinical significance of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in gastric cancer

The Value of Mg7-Ag and Cox-2 for Predicting Malignancy in Gastric Precancerous Lesions

Connexin 32 and 43 Promoter Methylation in Helicobacter Pylori-Associated Gastric Tumorigenesis

Discovery and Validation of Novel Methylation Markers in Helicobacter Pylori-Associated Gastric Cancer

Expression and Biological Activity of COX-2 Gene in Human Gastric Cancer Cell Lines